Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/50717
Title: An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis
Authors: Lekamwasam, S.
Adachi, J. D.
Agnusdei, D.
Bilezikian, J.
Boonen, S.
Borgström, F.
Cooper, C.
Perez, A. Diez
Eastell, R.
Hofbauer, L. C.
Kanis, J. A.
Langdahl, B. L.
Lesnyak, O.
Lorenc, R.
McCloskey, E.
Messina, O. D.
Napoli, N.
Obermayer-Pietsch, B.
Ralston, S. H.
Sambrook, P. N.
Silverman, S.
Sosa, M. 
Stepan, J.
Suppan, G.
Wahl, D. A.
Compston, J. E.
Issue Date: 2012
Publisher: 1862-3522
Journal: Archives of Osteoporosis 
Abstract: The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. © 2012 International Osteoporosis Foundation and National Osteoporosis Foundation.
URI: http://hdl.handle.net/10553/50717
ISSN: 1862-3522
DOI: 10.1007/s11657-012-0070-7
Source: Archives of Osteoporosis[ISSN 1862-3522],v. 7, p. 25-30
Appears in Collections:Artículos
Show full item record

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.